Stay updated on Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a Locations section listing Pennsylvania as the study site and removed the old Pennsylvania Locations entry. Updated page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-22T00:00:39.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision label updated from v3.3.1 to v3.3.2. The previous revision label v3.3.1 is removed.
    Difference
    0.1%
    Check dated 2025-11-30T10:16:05.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and revision: v3.2.0 was removed from the page, representing a minor metadata update. No visible changes to core content, study details, or functionality were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-23T07:51:06.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The government funding lapse notice about updates and NIH operation status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-16T05:51:31.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Minor cosmetic adjustments to page layout and formatting were observed, with no changes to core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-01T23:56:11.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Important updates include a notice about potential funding-related outages and current operating status, plus a version bump to v3.2.0. If this is a public-facing page, the new operating status information is the key change.
    Difference
    4%
    Check dated 2025-10-04T03:08:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.